Nonproteolytic K29-Linked Ubiquitination of the PB2 Replication Protein of Influenza A Viruses by Proviral Cullin 4-Based E3 Ligases.
A549 Cells
Cullin Proteins
/ genetics
HEK293 Cells
Host-Pathogen Interactions
Humans
Influenza A virus
/ chemistry
Protein Processing, Post-Translational
Proviruses
/ enzymology
RNA-Dependent RNA Polymerase
/ chemistry
Ubiquitin-Protein Ligases
/ metabolism
Ubiquitination
Viral Proteins
/ chemistry
Virus Replication
K29-linked ubiquitination
PB2 replication protein
cullin-based E3 ligases
influenza virus
nonproteolytic ubiquitination
post-translational modification
ubiquitination
Journal
mBio
ISSN: 2150-7511
Titre abrégé: mBio
Pays: United States
ID NLM: 101519231
Informations de publication
Date de publication:
07 04 2020
07 04 2020
Historique:
entrez:
9
4
2020
pubmed:
9
4
2020
medline:
18
2
2021
Statut:
epublish
Résumé
The multifunctional nature of viral proteins is essentially driven by posttranslational modifications (PTMs) and is key for the successful outcome of infection. For influenza A viruses (IAVs), a composite pattern of PTMs regulates the activity of viral proteins. However, almost none are known that target the PB2 replication protein, except for inducing its degradation. We show here that PB2 undergoes a nonproteolytic ubiquitination during infection. We identified E3 ubiquitin ligases catalyzing this ubiquitination as two multicomponent RING-E3 ligases based on cullin 4 (CRL4s), which are both contributing to the levels of ubiquitinated forms of PB2 in infected cells. The CRL4 E3 ligase activity is required for the normal progression of the viral cycle and for maximal virion production, indicating that the CRL4s mediate a ubiquitin signaling that promotes infection. The CRL4s are recruiting PB2 through an unconventional bimodal interaction with both the DDB1 adaptor and DCAF substrate receptors. While able to bind to PB2 when engaged in the viral polymerase complex, the CRL4 factors do not alter transcription and replication of the viral segments during infection. CRL4 ligases catalyze different patterns of lysine ubiquitination on PB2. Recombinant viruses mutated in the targeted lysines showed attenuated viral production, suggesting that CRL4-mediated ubiquitination of PB2 contributes to IAV infection. We identified K29-linked ubiquitin chains as main components of the nonproteolytic PB2 ubiquitination mediated by the CRL4s, providing the first example of the role of this atypical ubiquitin linkage in the regulation of a viral infection.
Identifiants
pubmed: 32265326
pii: mBio.00305-20
doi: 10.1128/mBio.00305-20
pmc: PMC7157767
pii:
doi:
Substances chimiques
CUL4A protein, human
0
Cullin Proteins
0
PB2 protein, Influenzavirus A
0
Viral Proteins
0
Ubiquitin-Protein Ligases
EC 2.3.2.27
RNA-Dependent RNA Polymerase
EC 2.7.7.48
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2020 Karim et al.
Références
J Virol. 2016 Nov 14;90(23):10906-10914
pubmed: 27681127
J Biochem. 2017 Feb 1;161(2):125-133
pubmed: 28011818
PLoS Pathog. 2015 Jun 09;11(6):e1004960
pubmed: 26057645
Proc Natl Acad Sci U S A. 2013 Oct 22;110(43):17516-21
pubmed: 24101521
Proc Natl Acad Sci U S A. 2015 Nov 10;112(45):14048-53
pubmed: 26504237
PLoS One. 2011;6(8):e23368
pubmed: 21853119
Nat Methods. 2011 Nov 29;8(12):990-2
pubmed: 22127214
J Proteome Res. 2007 Feb;6(2):672-82
pubmed: 17269724
mBio. 2011 Aug 16;2(4):
pubmed: 21846828
Elife. 2016 Apr 11;5:
pubmed: 27063938
J Virol. 2013 Apr;87(8):4523-33
pubmed: 23408607
Mol Cell. 2016 Jan 7;61(1):125-37
pubmed: 26711008
Mol Cell. 2009 Feb 13;33(3):275-86
pubmed: 19217402
J Gen Virol. 2001 Jul;82(Pt 7):1737-1747
pubmed: 11413386
PLoS Pathog. 2018 Sep 20;14(9):e1007205
pubmed: 30235357
Biomolecules. 2014 Oct 13;4(4):897-930
pubmed: 25314029
Curr Opin Chem Biol. 2004 Dec;8(6):610-6
pubmed: 15556404
mSphere. 2017 Nov 22;2(6):
pubmed: 29202037
Biochim Biophys Acta. 2014 Jan;1843(1):47-60
pubmed: 23747565
Sci Rep. 2017 Mar 02;7:43691
pubmed: 28252002
Cell Res. 2016 Apr;26(4):399-422
pubmed: 27012465
Nat Commun. 2016 Jun 07;7:11792
pubmed: 27273569
Nat Methods. 2015 Aug;12(8):787-93
pubmed: 26053890
Mol Cell. 2015 Apr 2;58(1):83-94
pubmed: 25752573
Trends Biochem Sci. 2009 Nov;34(11):562-70
pubmed: 19818632
J Biol Chem. 2017 Mar 3;292(9):3543-3551
pubmed: 28154183
Mol Cell. 2015 Apr 2;58(1):95-109
pubmed: 25752577
Virol J. 2006 Aug 31;3:63
pubmed: 16945126
Nature. 1995 Jan 5;373(6509):81-3
pubmed: 7800044
J Virol Methods. 2011 Apr;173(1):1-6
pubmed: 21185869
mBio. 2017 May 23;8(3):
pubmed: 28536288
J Virol. 2018 Jan 30;92(4):
pubmed: 29167343
Mol Cell Biol. 2013 Oct;33(20):4095-105
pubmed: 23959799
J Virol. 1999 Nov;73(11):9679-82
pubmed: 10516084